BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution manufacturers in global in-vitro diagnostics market since 2010. 

 

Bioperfectus was listed at Shanghai Stock Exchange (SSE: 688399), with headquarter located in Jiangsu, subsidiaries in Shanghai, Beijing, Xi’an, Tiaizhou, Hainan and Yinchuan. Bioperfectus is pioneering in molecular diagnostics market with our products ranging from real time PCR kits, nucleic acid extraction systems, rapid tests and automation laboratory devices etc... 

 

Since the inception of International Sales and Marketing Division in June, 2020, under the authorization of international renowned public health organizations and institutions, our products have been distributing in over 70 countries all over the world and about to come to cover more countries in the near future. 

 

Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream to create a healthier future for our next generations.  

Jiangsu Bioperfectus Technologies Co., Ltd

Stock Code: 688399

a leading molecular diagnostic solution provider